*Select test kits may be out of stock in some locations. Subject to availability.
COVID-19 testing is important to identify those who might have the virus and thus prevent continued spread, as well as to offer appropriate monitoring and treatments. The CDC recommends that anyone with any signs or symptoms of COVID-19 get tested, regardless of vaccination status or prior infection. For the continued safety of our patients, staff and store customers, purchasing an at-home test kit is highly recommended. This is especially recommended for patients currently exhibiting any COVID-19 symptoms.
The Kroger Health COVID-19 Test Home Collection Kit is available for over-the-counter purchase at select pharmacy locations. Contact your local pharmacy to confirm test availability. Over the counter COVID-19 rapid antigen testing options are also available at most pharmacies.
At this time, COVID-19 antibody testing is not available at Our Family of Pharmacies.
Common symptoms include fever, chills, cough, shortness of breath, fatigue, and/or new loss of taste or smell. For the complete list of COVID-19 symptoms and what you can do to better protect yourself, please refer to the Centers for Disease Control and Prevention.
The COVID-19 Viral PCR Test, Rapid Antigen Test, and Rapid Antibody Test are available for individuals 1+. We offer many at-home tests that may vary by age restrictions. Browse all at-home test kits here.
The Kroger Health COVID-19 Test Home Collection Kit relies on a nasal swab.
The BinaxNOW COVID-19 Antigen Self-Test relies on a nasal swab.
The QuickVue At-Home OTC COVID-19 Test relies on a nasal swab.
The results of all rapid tests will be available within approximately 15-30 minutes. The results for the send-out tests are typically available within 72 to 96 hours, since they are sent to an off-site approved lab for processing. Positive results will be reported to you over the phone by one of our providers, along with recommendations for follow-up care.
Physician referrals are NOT required for any of the COVID-19 tests.
†The molecular, antigen, and antibody (collectively, “Tests”) have not been FDA cleared or approved;
All Tests have been authorized by FDA under EUAs for use by authorized laboratories or are CLIA-waived tests;
The molecular tests have been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses. or pathogens;
The antigen tests have been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens;
The antibody tests have been authorized only for the presence of IgM and IgG antibodies against SARS-CoV-2, not for any other viruses or pathogens; and,
Tests are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.